Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,697 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,751
Recruiting: 1,519
Ph III recruiting: 167
Growth YoY: +8.6%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,318)

clinicaltrialsPublishedShowing 801–812 of 812 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00848094	Radiation Dose Escalation Study for Advanced Liver Cancer	completed	Phase 1	40	Fudan UniversityOTHER	0	Feb 20, 2009	clinicaltrials
NCT00043407	CPG 7909 in Patients Wih Stage IV Renal Cell Cancer	completed	Phase 1 / Phase 2	42	PfizerINDUSTRY	0	Feb 12, 2009	clinicaltrials
NCT00421512